|
|
Line 711: |
Line 711: |
| ==Adenoid cystic carcinoma== | | ==Adenoid cystic carcinoma== |
| :See: ''[[Adenoid cystic carcinoma of the breast]]'' for the [[breast]] tumour. | | :See: ''[[Adenoid cystic carcinoma of the breast]]'' for the [[breast]] tumour. |
| ===General===
| | {{Main|Adenoid cystic carcinoma}} |
| *Common malignant neoplasm of salivary gland.
| |
| *AKA ''cylindroma''.<ref>Chest. May 1957. Vol. 31. No. 5. PP. 493-511. [http://www.chestjournal.org/content/31/5/493.abstract http://www.chestjournal.org/content/31/5/493.abstract]</ref>
| |
| **Should ''not'' be confused with ''[[dermal cylindroma]]'' (a benign skin tumour).
| |
| *Composed of ductal cells and myoepithelial cells; '''myoepithelial cells''' > ductal cells.
| |
| | |
| ===Microscopic===
| |
| Features:
| |
| *Cribriform architecture ''or'' pseudoglandular spaces (classic pattern) - '''important feature'''.
| |
| **Other patterns: solid, cords, (bilayered) tubules.
| |
| **Cystic spaces filled with basophilic material (that is PAS +ve) - '''key feature'''.
| |
| *Scant cytoplasm in most cells (myoepithelial cells) - clear/eosinophilic.
| |
| **Moderate eosinophilic cytoplasm in the (rare) ductal cells.
| |
| *Nucleus - small.
| |
| **May be angulated (carrot-shaped) - myoepithelial cells; round/ovoid in ductal cells.
| |
| *Hyaline stroma.
| |
| | |
| Memory device:
| |
| *A'''d'''CC - mostly '''D'''NA (scant cytoplasm), distinct nucleus (carrot-shaped).
| |
| | |
| Notes:
| |
| *'''Squamous differentiation is extremely rare'''. It presence should prompt consideration of:
| |
| **Basaloid [[squamous cell carcinoma]].
| |
| **[[Basal cell carcinoma]] (BCC).
| |
| | |
| DDx:
| |
| *[[Pleomorphic adenoma]], esp. if encapsulated.
| |
| | |
| ====Images====
| |
| <gallery>
| |
| Image:Adenoid_cystic_carcinoma_-_intermed_mag.jpg | AdCC - intermed. mag. (WC/Nephron)
| |
| Image:Adenoid_cystic_carcinoma_-_high_mag.jpg | AdCC - high mag. (WC/Nephron)
| |
| Image:Adenoid_cystic_carcinoma_-a-_very_high_mag.jpg | AdCC - very high mag. (WC/Nephron)
| |
| </gallery>
| |
| www:
| |
| *[http://www.nature.com/modpathol/journal/v16/n12/fig_tab/3880915f2.html Adenoid cystic carcinoma (nature.com)].
| |
| | |
| ====Grading====
| |
| Based on solid component:
| |
| *Low grade = tubules and cribriform structures only; no solid component.
| |
| *Intermediate grade = solid component <30%.
| |
| *High grade = solid component >=30%
| |
| | |
| ===Stains===
| |
| Special stains:
| |
| *PAS +ve material - cystic spaces.<ref name=pc_add>URL: [http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970070-5 http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970070-5]. Accessed on: 12 May 2011.</ref>
| |
| | |
| ===IHC===
| |
| Features:<ref name=pmid19360297>{{Cite journal | last1 = Sequeiros-Santiago | first1 = G. | last2 = García-Carracedo | first2 = D. | last3 = Fresno | first3 = MF. | last4 = Suarez | first4 = C. | last5 = Rodrigo | first5 = JP. | last6 = Gonzalez | first6 = MV. | title = Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. | journal = Oncol Rep | volume = 21 | issue = 5 | pages = 1215-22 | month = May | year = 2009 | doi = | PMID = 19360297 }}</ref>
| |
| *CD117 +ve.
| |
| *Cyclin D1 +ve.
| |
| *Myoepithelial markers (e.g. calponin, actin) +ve.
| |
| **Typically -ve in PLGA.
| |
| | |
| ===Molecular===
| |
| Features:<ref>{{Cite journal | last1 = Mitani | first1 = Y. | last2 = Rao | first2 = PH. | last3 = Futreal | first3 = PA. | last4 = Roberts | first4 = D. | last5 = Stephens | first5 = P. | last6 = Zhao | first6 = YJ. | last7 = Zhang | first7 = L. | last8 = Mitani | first8 = M. | last9 = Weber | first9 = RS. | title = Novel Chromosomal Rearrangements and breakpoints at the t(6;9) in Salivary Adenoid Cystic Carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. | journal = Clin Cancer Res | volume = | issue = | pages = | month = Oct | year = 2011 | doi = 10.1158/1078-0432.CCR-11-1870 | PMID = 21976542 }}</ref>
| |
| *t(6;9) MYB-NFIB.
| |
| **Seen in ~50% of cases.
| |
| **Worse prognosis if present, esp. if fusion assoc. with transcription.
| |
|
| |
|
| ==Salivary duct carcinoma== | | ==Salivary duct carcinoma== |